End points in advanced colon cancer clinical trials: A review and proposal

被引：68

作者：

Allegra, Carmen ^{[1
]}

Blanke, Charles

Buyse, Marc

Goldberg, Richard

Grothey, Axel

Meropol, Neal J.

Saltz, Leonard

Venook, Alan

Yothers, Greg

Sargent, Daniel

机构：

[1] Univ Florida, Gainesville, FL 32602 USA

[2] Oregon Hlth & Sci Univ, Portland, OR 97201 USA

[3] Int Inst Drug Dev, Louvain, Belgium

[4] Univ N Carolina, Chapel Hill, NC USA

[5] Mayo Clin, Rochester, MN USA

[6] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA

[7] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[8] Univ Calif San Francisco, San Francisco, CA 94143 USA

[9] Univ Pittsburgh, Pittsburgh, PA USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 24期

关键词：

D O I：

10.1200/JCO.2007.12.1368

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3572 / 3575

页数：4

共 14 条

[1]

DENLINGER CS, 2007, J CLIN ONCOL S, V25, pS225

[2]

El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360

[3]

Freedman Benjamin, 1990, IRB, V12, P1, DOI 10.2307/3564541

[4] Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: A North American intergroup trial [J].

Goldberg, Richard M. ;

Sargent, Daniel J. ;

Morton, Roscoe F. ;

Fuchs, Charles S. ;

Ramanathan, Ramesh K. ;

Williamson, Stephen K. ;

Findlay, Brian P. ;

Pitot, Henry C. ;

Alberts, Steven .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (21) :3347-3353

[5] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[6] Alzheimer's disease - Clinical trials and the logic of clinical purpose [J].

Karlawish, Jason .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (15) :1604-1606

[7]

Labianca R, 2006, J CLIN ONCOL, V24, p147S

[8] A comparison of three highly active antiretroviral treatment strategies consisting of non-nucleoside reverse transcriptase inhibitors, protease inhibitors, or both in the presence of nucleoside reverse transcriptase inhibitors as initial therapy (CPCRA 058 FIRST Study): a long-term randomised trial [J].

MacArthur, Rodger D. ;

Novak, Richard M. ;

Peng, Grace ;

Chen, Li ;

Xiang, Ying ;

Hullsiek, Katherine Huppler ;

Kozal, Michael J. ;

van den Berg-Wolf, Mary ;

Henely, Christopher ;

Schmetter, Barry ;

Dehlinger, Marjorie .

LANCET, 2006, 368 (9553) :2125-2135

[9]

Maindrault-Goebel F, 2006, J CLIN ONCOL, V24, p147S

[10] Comparison of intermittent and continuous palliative chemotherapy for advanced colorectal cancer: a multicentre randomised trial [J].

Maughan, TS ;

James, RD ;

Kerr, DJ ;

Ledermann, JA ;

Seymour, MT ;

Topham, C ;

McArdle, C ;

Cain, D ;

Stephens, RJ .

LANCET, 2003, 361 (9356) :457-464

← 1 2 →